IP Library Granted Patent US 6,966,926
Granted Patent B2
US 6,966,926 · App. 10/659,010 · Granted Nov 22, 2005

Mitral valve therapy assembly and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,966,926
App. No.
10/659,010
Granted
Nov 22, 2005
Kind
B2
Abstract

An assembly for effecting the condition of a mitral valve of a heart includes a mitral valve therapy device, a guide wire, and a guide tube. The mitral valve therapy device is configured to reshape the mitral valve annulus of the heart when placed within the coronary sinus adjacent the mitral valve annulus. The guide wire is configured to be fed into the coronary sinus of the heart adjacent the mitral valve annulus. The guide tube has a distal end, a proximal end, and a lumen extending between the distal end and the proximal end. The guide tube further includes a side port, intermediate the distal and proximal ends which communicates with the lumen. This permits the guide tube to be slidingly received on the guide wire with the guide wire extending from the distal end, through the lumen, and out the side port. In use, the guide tube is slid along the guide wire into the coronary sinus. The mitral valve therapy device is then delivered by the guide tube into the coronary sinus adjacent the mitral valve annulus.

Claims (23)

1. A method of deploying a mitral valve therapy device within the coronary sinus of a heart adjacent the mitral valve annulus, the method including the steps of:

A. providing an elongated flexible guide wire having a cross sectional dimension;

B. feeding guide wire into the coronary sinus of the heart;

C. providing an elongated flexible guide tube having a proximal end, a distal end, a lumen, and a side port communicating with the lumen;

D. feeding the guide tube into the coronary sinus of the heart with the guide wire extending through the lumen from the distal end to and through the side port;

E. providing a mitral valve therapy device configured to be slidingly received within the lumen of the guide tube, the device including a proximal end;

F. providing a flexible elongated introducer configured to be slidingly received within the lumen of the guide tube, the introducer having a distal end;

G. placing the device into the guide tube lumen;

H. placing the introducer into the guide tube lumen;

I. engaging the distal end of the introducer with the proximal end of the device;

J. pushing the device with the introducer in a distal direction within the guide tube lumen until the device is at least partially encircling the mitral valve within the coronary sinus of the heart; and

K. releasing the device from the guide tube into the coronary sinus of the heart adjacent to the mitral valve annulus.

2. The method of claim 1 wherein the step of placing the device into the guide tube lumen includes the step of placing the device on the guide wire.

3. The method of claim 1 wherein the step of placing the introducer into the guide tube lumen includes the step of placing the introducer on the guide wire.

4. The method of claim 1 including the further step of providing a delivery slot in the guide tube proximal to the side port and communicating with the lumen, and wherein the releasing step includes the step of advancing the device from the lumen through the delivery slot and into the coronary sinus.

5. The method of claim 1 wherein the releasing step includes the step of releasing the device from the distal end of the guide tube.

6. The method of claim 1 wherein the step of placing the device into the guide tube lumen includes placing the device on the guide wire and wherein the step of releasing the device includes releasing the device from the distal end of the guide tube.

7. The method of claim 6 including the further step of testing the effectiveness of the device while the device is on the guide wire.

8. The method of claim 1 including the further step of withdrawing the introducer, the guide tube, and the guide wire from the coronary sinus.

9. The method of claim 1 wherein the guide wire is visible under X ray fluoroscopy and wherein the method includes the further steps of:

inserting a second wire into the circumflex artery of the heart, the second wire being visible under X ray fluoroscopy;

subjecting the heart to X ray fluoroscopic examination to visualize the crossover point of the guide wire and the second wire; and

releasing the mitral valve annulus therapy device within the coronary sinus in a position such that the device is proximal to the crossover point of the guide wire and the second wire.

Assignments (5)
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 6, 2023
From: OXFORD FINANCE LLC
To: CARDIAC DIMENSIONS PTY LTD
Reel/Frame 064224/0199 →
FIRST AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 27, 2023
From: CARDIAC DIMENSIONS PTY LTD
To: OXFORD FINANCE LLC
Reel/Frame 063167/0447 →
SECURITY INTEREST Recorded Apr 16, 2018
From: CARDIAC DIMENSIONS PTY LTD
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 045958/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2014
From: CARDIAC DIMENSIONS, INC.
To: CARDIAC DIMENSIONS PTY. LTD.
Reel/Frame 032759/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2006
From: MATHIS, MARK L.
To: CARDIAC DIMENSIONS, INC.
Reel/Frame 018334/0444 →